BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27531760)

  • 1. [Expression of miR-155 in Acute Myeloid Leukemia and Its Clinical Significance].
    Hu XL; Tang AP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):980-4. PubMed ID: 27531760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Value of miR-34a in Bone Marrow Mononuclear Cells of Acute Myeloid Leukemia Patients.
    Liu X; Li H
    Clin Lab; 2020 Mar; 66(3):. PubMed ID: 32162890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of miR-210 is Associated with Poor Prognosis of Acute Myeloid Leukemia.
    Tang X; Chen L; Yan X; Li Y; Xiong Y; Zhou X
    Med Sci Monit; 2015 Nov; 21():3427-33. PubMed ID: 26549593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
    Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
    Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression and Clinical Significance of PD-L1 and MicroRNA-138-5p in Patients with Acute Myeloid Leukemia].
    Huang CY; Zha XF; Wen WR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):373-378. PubMed ID: 30998140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low expression of microRNA-340 confers adverse clinical outcome in patients with acute myeloid leukemia.
    Wang Q; Feng T; Xu J; Miao MH; Ji XQ; Zhu H; Shao XJ
    J Cell Physiol; 2019 Apr; 234(4):4200-4205. PubMed ID: 30171606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low expression of microRNA-204 (miR-204) is associated with poor clinical outcome of acute myeloid leukemia (AML) patients.
    Butrym A; Rybka J; Baczyńska D; Tukiendorf A; Kuliczkowski K; Mazur G
    J Exp Clin Cancer Res; 2015 Jul; 34(1):68. PubMed ID: 26126974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum MicroRNA-370 as a potential diagnostic and prognostic biomarker for pediatric acute myeloid leukemia.
    Lin X; Wang Z; Wang Y; Feng W
    Int J Clin Exp Pathol; 2015; 8(11):14658-66. PubMed ID: 26823789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower expression of bone marrow miR-122 is an independent risk factor for overall survival in cytogenetically normal acute myeloid leukemia.
    Zhang TJ; Qian Z; Wen XM; Zhou JD; Li XX; Xu ZJ; Ma JC; Zhang ZH; Lin J; Qian J
    Pathol Res Pract; 2018 Jun; 214(6):896-901. PubMed ID: 29627222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of HOXB4, PRDM16 and HOXA9 in Patients with Acute Myeloid Leukemia and Its Clinical Significance].
    Li L; Zhao CT; Cui BL; Wu SL; Liu XD; Su Z; Yang J; Wang W; Cui ZG; Zhao HG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):326-31. PubMed ID: 27150986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulated miR-217 expression predicts a poor outcome in acute myeloid leukemia.
    Yan J; Wu G; Chen J; Xiong L; Chen G; Li P
    Cancer Biomark; 2018; 22(1):73-78. PubMed ID: 29439315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of WT1 gene in acute myeloid leukemia children by real-time fluorescent quantitative RT-PCR and its clinical significance].
    Zhang R; Sun HQ; Li G; Bai FY; Yang Y; Jing Q; Shi YJ; Yang JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):959-63. PubMed ID: 21867623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of miR-124-1 predicts favorable prognosis in acute myeloid leukemia.
    Chen XX; Lin J; Qian J; Qian W; Yang J; Ma JC; Deng ZQ; Xie D; An C; Tang CY; Qian Z
    Clin Biochem; 2014 Jan; 47(1-2):63-6. PubMed ID: 24135052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low miR-192 expression predicts poor prognosis in pediatric acute myeloid leukemia.
    Tian C; Zhang L; Li X; Zhang Y; Li J; Chen L
    Cancer Biomark; 2018; 22(2):209-215. PubMed ID: 29689705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High serum microRNA-335 level predicts aggressive tumor progression and unfavorable prognosis in pediatric acute myeloid leukemia.
    Lin X; Wang Z; Zhang R; Feng W
    Clin Transl Oncol; 2015 May; 17(5):358-64. PubMed ID: 25301405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low miR-34c expression is associated with poor outcome in de novo acute myeloid leukemia.
    Yang DQ; Zhou JD; Wang YX; Deng ZQ; Yang J; Yao DM; Qian Z; Yang L; Lin J; Qian J
    Int J Lab Hematol; 2017 Feb; 39(1):42-50. PubMed ID: 27577964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow miR-10a overexpression is associated with genetic events but not affects clinical outcome in acute myeloid leukemia.
    Zhang TJ; Guo H; Zhou JD; Li XX; Zhang W; Ma JC; Wen XM; Yao XY; Lin J; Qian J
    Pathol Res Pract; 2018 Jan; 214(1):169-173. PubMed ID: 29254789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of miR-34a in Bone Marrow of Adult Acute Lymphoblastic Leukemia and Its Significance in Cell Drug Resistance].
    Han B; Wang HX; Shao W; Han ZL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):336-40. PubMed ID: 27150988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of microRNA-331 can be used as a predictor for response to therapy and survival in acute myeloid leukemia patients.
    Butrym A; Rybka J; Baczyńska D; Tukiendorf A; Kuliczkowski K; Mazur G
    Biomark Med; 2015; 9(5):453-60. PubMed ID: 25620533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
    Pituch-Noworolska A
    Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.